-+ 0.00%
-+ 0.00%
-+ 0.00%

Propanc Advances Assay Development for PPC-001 Phase 1b Trial in Up to 50 Cancer Patients

PUBT·10/30/2026 12:31:24
Listen to the news
Propanc Advances Assay Development for PPC-001 Phase 1b Trial in Up to 50 Cancer Patients
  • Propanc Biopharma advanced analytical testing supporting a planned Phase 1b first-in-human trial of PPC-001 in up to 50 advanced cancer patients.
  • Laboratory results already reported showed PPC-001 components remained stable in human blood samples, supporting clinical sample collection procedures.
  • Ongoing assay development will support assessment of drug exposure and immune responses during the planned solid-tumor study.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Propanc Biopharma Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610300830PRIMZONEFULLFEED9856824) on October 30, 2026, and is solely responsible for the information contained therein.